Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bishop

Showing results (871-880 of 1,042) with videos related to

Pageof 105
Sort By:
Clinical Pharmacology and Therapeutics|May 15, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake InhibitorsJ K Hicks, J R Bishop, K Sangkuhl, et al.
Blood Advances|December 10, 2024
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysisPeter A Riedell, Connor B Grady, Loretta J Nastoupil, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Genetic Analysis of Psychosis Biotypes: Shared Ancestry-Adjusted Polygenic Risk and Unique Genomic AssociationsCuihua Xia, Ney Alliey-Rodriguez, Carol A Tamminga, et al.
Blood Advances|November 15, 2019
Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adultsBenjamin A Derman, Keriann Kordas, Jean Ridgeway, et al.
Blood|February 7, 2004
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cellsKouhei Yamashita, Uimook Choi, Patricia C Woltz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Haematologica|January 8, 2026
Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemiaElias Jabbour, Karamjeet S Sandhu, Paul Shaughnessy, et al.
Brain, Behavior, & Immunity - Health|May 2, 2022
Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disordersLusi Zhang, Paulo Lizano, Bin Guo, et al.
Schizophrenia Research|December 13, 2018
Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophreniaLeah H Rubin, Siyi Li, Li Yao, et al.
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.
Pageof 105

Showing results (871-880 of 1,042) with videos related to

Sort By:
Pageof 105
Clinical Pharmacology and Therapeutics|May 15, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake InhibitorsJ K Hicks, J R Bishop, K Sangkuhl, et al.
Blood Advances|December 10, 2024
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysisPeter A Riedell, Connor B Grady, Loretta J Nastoupil, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Genetic Analysis of Psychosis Biotypes: Shared Ancestry-Adjusted Polygenic Risk and Unique Genomic AssociationsCuihua Xia, Ney Alliey-Rodriguez, Carol A Tamminga, et al.
Blood Advances|November 15, 2019
Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adultsBenjamin A Derman, Keriann Kordas, Jean Ridgeway, et al.
Blood|February 7, 2004
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cellsKouhei Yamashita, Uimook Choi, Patricia C Woltz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 13, 2011
National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committeeMichael R Bishop, Edwin P Alyea, Mitchell S Cairo, et al.
Haematologica|January 8, 2026
Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemiaElias Jabbour, Karamjeet S Sandhu, Paul Shaughnessy, et al.
Brain, Behavior, & Immunity - Health|May 2, 2022
Inflammation subtypes in psychosis and their relationships with genetic risk for psychiatric and cardiometabolic disordersLusi Zhang, Paulo Lizano, Bin Guo, et al.
Schizophrenia Research|December 13, 2018
Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophreniaLeah H Rubin, Siyi Li, Li Yao, et al.
Bone Marrow Transplantation|April 4, 2000
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemiaZ S Pavletic, E R Arrowsmith, P J Bierman, et al.
Pageof 105